Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Nantahala Capital Management, LLC Stock Portfolio

$1.75Billion– No. of Holdings #110

Nantahala Capital Management, LLC Performance:
2024 Q1: 7.98%YTD: 7.98%2023: -2.26%

Performance for 2024 Q1 is 7.98%, and YTD is 7.98%, and 2023 is -2.26%.

About Nantahala Capital Management, LLC and 13F Hedge Fund Stock Holdings

Nantahala Capital Management, LLC is a hedge fund based in NEW CANAAN, CT. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.5 Billions. In it's latest 13F Holdings report, Nantahala Capital Management, LLC reported an equity portfolio of $1.8 Billions as of 31 Mar, 2024.

The top stock holdings of Nantahala Capital Management, LLC are SLNO, ESTA, CASH. The fund has invested 5.9% of it's portfolio in SOLENO THERAPEUTICS INC and 5.7% of portfolio in ESTABLISHMENT LABS HLDGS INC.

The fund managers got completely rid off CYTOKINETICS INC (CYTK), AMYLYX PHARMACEUTICALS INC (AMLX) and ARS PHARMACEUTICALS INC (SBTX) stocks. They significantly reduced their stock positions in LUXFER HLDGS PLC (LXFR), AN2 THERAPEUTICS INC (ANTX) and TARSUS PHARMACEUTICALS INC (TARS). Nantahala Capital Management, LLC opened new stock positions in EAGLE PHARMACEUTICALS INC (EGRX), SILENCE THERAPEUTICS PLC (SLN) and MINERALYS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to CONNS INC (CONN), ZYNEX INC (ZYXI) and FOSSIL GROUP INC (FOSL).
Nantahala Capital Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

Nantahala Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Nantahala Capital Management, LLC made a return of 7.98% in the last quarter. In trailing 12 months, it's portfolio return was 4.8%.

New Buys

Ticker$ Bought
eagle pharmaceuticals inc6,595,910
silence therapeutics plc4,320,000
mineralys therapeutics inc4,292,650
newamsterdam pharma company4,138,750
spdr ser tr3,991,930
milestone pharmaceuticals in3,132,500
the one group hospitality in3,050,740
achieve life sciences inc2,972,430

New stocks bought by Nantahala Capital Management, LLC

Additions

Ticker% Inc.
conns inc146
zynex inc104
fossil group inc61.17

Additions to existing portfolio by Nantahala Capital Management, LLC

Reductions

Ticker% Reduced
luxfer hldgs plc-81.07
an2 therapeutics inc-80.21
tarsus pharmaceuticals inc-79.97
immatics n.v-72.14
kintara therapeutics inc-71.02
perella weinberg partners-67.96
neuropace inc-66.85
dyne therapeutics inc-66.14

Nantahala Capital Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
cartesian therapeutics inc-3,080,530
ars pharmaceuticals inc-17,497,700
societal cdmo inc-851,508
startek inc-6,940,570
amylyx pharmaceuticals inc-18,256,000
eargo inc-2,567,110
dianthus therapeutics inc-6,831,410
sensus healthcare inc-834,260

Nantahala Capital Management, LLC got rid off the above stocks

Sector Distribution

Nantahala Capital Management, LLC has about 55% of it's holdings in Healthcare sector.

Sector%
Healthcare55
Consumer Cyclical13.9
Others9.3
Financial Services6.9
Communication Services5.9
Technology3.7
Industrials3.4
Real Estate1.8

Market Cap. Distribution

Nantahala Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP53.9
MICRO-CAP25.2
UNALLOCATED8.8
MID-CAP6.8
NANO-CAP5.3

Stocks belong to which Index?

About 0% of the stocks held by Nantahala Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others100
Top 5 Winners (%)%
RZLT
rezolute inc
154.9 %
UNCY
unicycive therapeutics inc
126.0 %
DYN
dyne therapeutics inc
86.2 %
ESTA
establishment labs hldgs inc
67.8 %
MAX
mediaalpha inc
60.3 %
Top 5 Winners ($)$
ESTA
establishment labs hldgs inc
86.7 M
SLNO
soleno therapeutics inc
27.1 M
EOLS
evolus inc
19.3 M
DYN
dyne therapeutics inc
14.7 M
KROS
keros therapeutics inc
14.2 M
Top 5 Losers (%)%
ANTX
an2 therapeutics inc
-82.6 %
PLCE
childrens pl inc new
-43.4 %
KTRA
kintara therapeutics inc
-36.8 %
FBIO
fortress biotech inc
-34.8 %
ASPS
altisource portfolio solns s
-33.6 %
Top 5 Losers ($)$
RMBL
rumbleon inc
-12.9 M
PTON
peloton interactive inc
-11.7 M
ANTX
an2 therapeutics inc
-8.4 M
QURE
uniqure nv
-8.2 M
CRMT
americas car-mart inc
-7.8 M

Nantahala Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Nantahala Capital Management, LLC

Nantahala Capital Management, LLC has 110 stocks in it's portfolio. About 26.9% of the portfolio is in top 10 stocks. RMBL proved to be the most loss making stock for the portfolio. ESTA was the most profitable stock for Nantahala Capital Management, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions